Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point
Go back to Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 239.72 -0.35 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.07 | 52 Week High | $160.00 | |||
| Open | $238.38 | 52 Week Low | $95.80 | |||
| Day High | $239.72 | P/E | 44.56 | |||
| Day Low | $236.00 | EPS | $5.38 | |||
| Volume | 18,765 | |||||
